More Videos
SPECIAL REPORT
MOST SHARED
- Ritz-Carlton ?Struggling? in the US: President
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Garlic Price Rises Surpass Gold, Stocks in China
- Oil Price to Average $75.40 in 2010: Poll
- Obama Reiterates Commitment to Boost US-India Ties
- Half of Banks' Losses May Still Be Hidden: IMF Head
- New-Home Sales Jump 6.2% To Highest Level in Over Year
- Jobless Claims Below 500,000, Durable Orders Slip
- Americans Ditch Planes for Trains this Thanksgiving
- Investors Thankful for Gains This Year
- Thanksgiving & the Markets
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
- Topless Business Is Taking Off
- 3 Software Stock Picks from Lazard's Senior Analyst
- Schork Oil Outlook: Gas Bulls Pinning Hopes on Mother Nature
- Toyota Makes Recall Fix And So Long Saab
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
- New-Home Sales Jump to Highest Level in Over Year
- Consumer Mood Improves, But Anxiety Over Finances
- Jobless Claims Below 500,000, Durable Orders Slip
- For Many Americans, a Scaled-Down Holiday Season
- Garlic Price Rises Surpass Gold, Stocks in China
- Judge Erases Couple's $525,000 Mortgage Payment
- Black Friday: Can Banks Tap the Frenzy, Too?
- Half of Banks' Losses May Still Be Hidden: IMF Head
- Seeking Deals, Holiday Fliers Get Early Start
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
Text Size 
 |
AP |
Intraday, at least, shares of the Dow component have broken above $20--just barely, though. If the stock can stay there at 4 p.m. ET today, our resident stock statistician, Robert Hum, says that'll be the first time Pfizer's closed above that level since May 21st.
Coincidentally, Leerink Swann's big pharma analyst Seamus Fernandez is out with a research note to clients on PFE today. He's raising his sales and earnings forecasts for 2011 and 2012, but cutting his EPS projections for 2009 and 2010.
It's essentially a wash because Fernandez writes, "Still-negative outlook keeps us on the sidelines." He also thinks the big Pfizer dividend is "likely safe" through '12 as long as there are no "major shocks or mega-mergers". After 2012, Fernandez isn't so sure about the dividend. That's when the loss of the patent on the mega-blockbuster cholesterol drug will be in full effect.
Leerink Swann may trade in PFE [PFE
Loading...
()
].
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes